After hours: January 10 at 6:11:07 PM EST Loading Chart for PTC ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

Stifel raised the firm’s price target on PTC (PTC) to $230 from $200 and keeps a Buy rating on the shares. After a bumpy start to 2024, the year is “ending on a higher note” for the ...

PTC Therapeutics (PTCT) submitted the vatiquinone New Drug Application, or NDA, for the treatment of children and adults living with Friedreich ataxia, or FA, to the FDA. The vatiquinone NDA is ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

PTC Industries recently announced the completion of its acquisition of Trac Precision Solutions. PTC Industries in its release on 19 December, informed the exchanges and investors about the ...

- PTC's fourth approval application submitted to FDA in 2024 - WARREN, N.J., Dec. 19, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the submission of the vatiquinone ...

PTC India Financial Services Ltd., incorporated in the year 2006, is a Small Cap company (having a market cap of Rs 2,420.12 Crore) operating in Term Lending Institutions sector. PTC India Financial ...

Morgan Stanley has upgraded PTC Therapeutics (NASDAQ:PTCT), while downgrading Immuneering (NASDAQ:IMRX) and Amicus Therapeutics (NASDAQ:FOLD). The investment bank raised its rating on PTC (NASDAQ ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.